Sintodril en es it fr

Sintodril Brand names, Sintodril Analogs

Sintodril Brand Names Mixture

  • No information avaliable

Sintodril Chemical_Formula


Sintodril RX_link

Sintodril fda sheet

Sintodril msds (material safety sheet)

Sintodril MSDS

Sintodril Synthesis Reference

No information avaliable

Sintodril Molecular Weight

166.24 g/mol

Sintodril Melting Point

No information avaliable

Sintodril H2O Solubility

Appreciable as liquid hydrochloride salt

Sintodril State


Sintodril LogP


Sintodril Dosage Forms

Liquid for injection

Sintodril Indication

For the differential diagnosis of myasthenia gravis and as an adjunct in the evaluation of treatment requirements in this disease. It may also be used for evaluating emergency treatment in myasthenic crises.

Sintodril Pharmacology

Edrophonium is a short and rapid-acting anticholinesterase drug. Its effect is manifest within 30 to 60 seconds after injection and lasts an average of 10 minutes. Edrophonium's pharmacologic action is due primarily to the inhibition or inactivation of acetylcholinesterase at sites of cholinergic transmission. Muscarinic receptors are found throughout the body, especially on muscle. Stimulation of these receptors causes to muscle contraction. In myasthenia gravis the body's immune system destroys many of the muscarinic receptors, so that the muscle becomes less responsive to nervous stimulation. Edrophonium chloride increases the amount of acetylcholine at the nerve endings. Increased levels of acetyl choline allow the remaining receptors to function more efficiently.

Sintodril Absorption

Rapidly absorbed.

Sintodril side effects and Toxicity

With drugs of this type, muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage (cholinergic crisis).

Sintodril Patient Information

No information avaliable

Sintodril Organisms Affected

Humans and other mammals